Metabolic effects of pamidronate in patients with metastatic bone disease.
We have evaluated the value of specific bone resorption markers in monitoring metastatic bone disease to define the duration of action of a single high-dose pamidronate infusion. Twenty patients received a single infusion of pamidronate 120 mg for painful bone metastases. Ten out of these 20 patient...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
1996
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074415/ |